Page last updated: 2024-11-04

vorinostat and Eye Burns

vorinostat has been researched along with Eye Burns in 2 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Eye Burns: Injury to any part of the eye by extreme heat, chemical agents, or ultraviolet radiation.

Research Excerpts

ExcerptRelevanceReference
" Additional in vivo SAHA dosing studies with larger sample size are warranted."1.43Development of a novel in vivo corneal fibrosis model in the dog. ( Bunyak, F; Giuliano, EA; Gronkiewicz, KM; Hamm, CW; Kuroki, K; Mohan, RR; Sharma, A; Teixeira, LB, 2016)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gronkiewicz, KM1
Giuliano, EA1
Kuroki, K1
Bunyak, F1
Sharma, A1
Teixeira, LB1
Hamm, CW1
Mohan, RR1
Li, X1
Zhou, Q1
Hanus, J1
Anderson, C1
Zhang, H1
Dellinger, M1
Brekken, R1
Wang, S1

Other Studies

2 other studies available for vorinostat and Eye Burns

ArticleYear
Development of a novel in vivo corneal fibrosis model in the dog.
    Experimental eye research, 2016, Volume: 143

    Topics: Actins; Animals; Biomarkers; Burns, Chemical; Cornea; Corneal Diseases; Disease Models, Animal; Dogs

2016
Inhibition of multiple pathogenic pathways by histone deacetylase inhibitor SAHA in a corneal alkali-burn injury model.
    Molecular pharmaceutics, 2013, Jan-07, Volume: 10, Issue:1

    Topics: Alkalies; Animals; Burns, Chemical; Cornea; Corneal Diseases; Corneal Injuries; Corneal Neovasculari

2013